<?xml version="1.0" encoding="UTF-8"?>
<ref id="pmed.1002882.ref072">
 <label>72</label>
 <mixed-citation publication-type="other">Dooley KE, Radojka GC, Savic M, Gupte A, Marzinke MA, Zhang N, et al. Safety &amp; PK of weekly rifapentine/isoniazid (3HP) in adults with HIV on dolutegravir. In: Conference on Retroviruses and Opportunistic Infections [abstract]; 2019 Mar 4â€“7; Seattle, WA. Available from: 
  <ext-link ext-link-type="uri" xlink:href="http://www.croiconference.org/sessions/safety-pk-weekly-rifapentineisoniazid-3hp-adults-hiv-dolutegravir" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.croiconference.org/sessions/safety-pk-weekly-rifapentineisoniazid-3hp-adults-hiv-dolutegravir</ext-link>. Cited 2019 May 18.
 </mixed-citation>
</ref>
